Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

This is a double-blind, randomized, two x two crossover (aprepitant vs placebo) during both initiation of Entresto, LCZ696, (50 mg dose) and at steady-state of Entresto (200 mg bid dose or the

angiotensin ii receptor antagonists
angiotensin
b-type natriuretic peptide
heart failure
beta blockers
  • 0 views
  • 15 Jun, 2022
  • 1 location
The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

This study sought to investigate the efficacy and safety of a three-drug combination antiemetic regimen of olanzapine combined with aprepitant and palonosetron for the prevention of

palonosetron
aprepitant
cavity
nausea
carcinoma
  • 0 views
  • 21 Mar, 2022
Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

chemotherapy, which means 5-HT receptor antagonist would be a effective medicine for acute CINV. In addition, there are researches proclaimed that neurokinin-1 (NK-1) receptor antagonist, aprepitant, is a

carboplatin
metastasis
neutrophil count
adverse effect
lung cancer
  • 3 views
  • 12 Feb, 2022
  • 2 locations
Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

Uterine serous carcinoma (USC) is an uncommon, but aggressive variant of endometrial carcinoma that has poor response to standard therapy. After staging and surgery, radiation therapy and/or chemotherapy is recommended to treat patients at high risk for recurrence. In advanced stage and recurrent setting, high risk uterine cancer mirrors ovarian …

carboplatin
metastasis
hysterectomy
ovarian cancer
carcinoma
  • 0 views
  • 25 Nov, 2021
  • 1 location